Peer-Reviewed University Trial Finds NOVOS Core Improved Three Key Measures of Cardiovascular Health in Healthy Adults
Published in the European Heart Journal Open, the University of Surrey study gives longevity science early human evidence that supporting the biology of aging improves the systems that depend on it NEW YORK, Nov. 4, 2026 /PRNewswire/ -- Longevity has become one of the fastest-growing...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 153 stories mentioning NOV, the earliest published 7 Oct 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.